Skip to main content
. 2022 Oct 5;158(12):1357–1366. doi: 10.1001/jamadermatol.2022.3917

Figure 1. Clinical Photographs.

Figure 1.

A, Patient 2, with erythematous plaques with white scale on the scalp at enrollment. B, Patient 2, with resolution of active lesions 6 months after apremilast. C, Patient 4, with erythematous to violaceous plaques with white scale in a characteristic V neck distribution on the chest. D, Patient 4, with resolution of active lesions 6 months after apremilast with remaining faint telangiectasia.